Galaxy Surfactants reported a 109% YoY rise in Q1FY27 net profit to Rs 165.9 crore, triggering a 20% upper‑circuit surge. Revenue grew 38.5% and EBITDA hit a record Rs 252.5 crore, driven by stronger volumes and specialty care demand.

Key Takeaways

  • Net profit up 108.7% to Rs 165.9 crore
  • Revenue up 38.5% to Rs 1,785.2 crore
  • Record EBITDA Rs 252.5 crore, up 86.9% YoY

Key Financial Highlights

Galaxy Surfactants posted a record quarterly EBITDA of Rs 252.5 crore in Q1FY27, while revenue surged 38.5% YoY to Rs 1,785.2 crore. The stock hit a 20% upper circuit at Rs 2,505.60 on the BSE.

Consolidated net profit rose 108.7% YoY to Rs 165.9 crore, and 165.8% sequentially from Q4FY26. Operating profit margin widened to 14.1% from 10.5% a year earlier.

Why This Matters

BozokMedia analysis shows that the surge reflects robust demand for specialty care products and an improved product mix, positioning the company ahead of peers in the home‑and‑personal‑care chemicals segment.

"Galaxy Surfactants' disciplined pricing and supply‑chain agility have been pivotal to this performance," says market analyst Rajesh Mehta.

Historical Background

Over the past five years, the firm transitioned from bulk chemicals to high‑margin specialty surfactants, steadily improving margins and expanding its global footprint. This strategic shift has underpinned consistent revenue growth and profitability.

Did You Know?: Galaxy Surfactants crossed the Rs 10,000 crore revenue mark for the first time in 2022.

Frequently Asked Questions

Q1: What drove the profit surge in Q1FY27?
Answer: Strong product mix, higher contribution from specialty care, and disciplined pricing actions.

Q2: What is the outlook for the company?
Answer: Management is confident about sustained growth, citing robust domestic demand and recovering international specialty care markets.